ISDS Case Map
intellectual property
The Obama administration on Monday sought to allay concerns that the U.S. push for stronger drug patent protections in a Transpacific trade deal would raise the cost of life-saving treatments out of the reach of the region's poor people.
In June, the US and South Korean governments clarified that US cheese manufacturers will be able to continuing shipping to Korea a wide variety of cheeses of importance to the US dairy industry despite the EU-Korea FTA's provisions on geographical indications
The 10th International Conference on AIDS in Asia and the Pacific (ICAAP10) has been turned upside down completely
An anti-Free Trade Agreement protest that took place outside an International Congress on AIDS in the Asia Pacific (ICAAP) in Busan, South Korea, on 27 August was violently attacked by police.
Critics of the proposed Trans-Pacific Partnership Agreement (TPP) gathered in Washington to voice concerns over the US’s stronghold on intellectual property rights.
The National Farmers Union (NFU) has joined voices with the Council of Canadians to warn Canadians in general and the agricultural community in particular about the dangers/threat of the Comprehensive and Economic Trade Agreement (CETA) being forged between Canada and the European Union.
CETA IPR chapter will likely have a slight positive effect on specific industries in the EU, such as agri-food companies using geographical indications. It would also benefit the Canadian publishing industry and the innovative pharmaceutical industry. At the same time, an IPR chapter in CETA could lead to notable negative effects in Canada, for example via higher prices on educational and pharmaceutical products.
Civil society groups say a leaked document from regional free trade negotiations between countries bordering the Pacific Ocean shows the United States favouring giant pharmaceutical companies at the expense of public health.
While ‘data exclusivity’ clauses will not feature in the India-European Union free trade agreement (FTA), the threat posed by the impending deal to the world’s supply of cheap generic drugs is far from over.
The European Union has informed the WTO that it is pressing for inclusion of strong IPR regime in the free trade agreement under negotiations with India even as the Commerce Ministry has maintained that New Delhi will not yield to the EU on this issue.
